MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$120,877K
Net Income
-$16,790K
Net Profit Margin
-13.89%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
Product IBSRELA
Product XPHOZAH
Revenue From Contract With Custo...
Others
Revenue Breakdown
Product
Product Supply Revenue
Non Cash Royalty Related To Sale...
License
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
120,877
94,473
125,215
110,329
Cost of sales
5,759
4,811
10,849
3,982
Research and development
26,103
20,188
22,856
18,067
Selling, general and administrative
101,440
102,267
86,411
83,612
Total costs and operating expenses
133,302
127,266
148,804
101,679
Gain from operations
-12,425
-32,793
5,099
4,668
Interest expense
4,957
5,599
5,759
5,796
Non-cash interest expense related to the sale of future royalties
1,267
1,317
1,818
2,188
Other income, net
2,038
2,112
2,078
2,449
Loss before provision for income taxes
-16,611
-37,597
-400
-867
Provision for income taxes
110
8
7
102
Net loss
-16,721
-37,605
-407
-969
Unrealized losses on available-for-sale securities
-69
-322
74
162
Comprehensive loss
-16,790
-37,927
-333
-807
Basic EPS
-0.07
-0.15
-0.001
0
Diluted EPS
-0.07
-0.15
-0.001
0
Basic Average Shares
248,067,253
245,855,082
243,673,878
241,908,407
Diluted Average Shares
248,067,253
245,855,082
243,673,878
241,908,407
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Comprehensive loss
-$16,790K
(12.26%↑ Y/Y)
Revenue From Contract
With Customer...
$1,976K
License Agreement
Development...
$95K
Knight Therapeutics
Inc-License Agreement...
$1K
Net loss
-$16,721K
(12.36%↑ Y/Y)
Unrealized losses on
available-for-sale securities
-$69K
(-23.21%↓ Y/Y)
Product IBSRELA
$86,243K
Product XPHOZAH
$31,886K
Product Supply Revenue
$1,976K
(-68.05%↓ Y/Y)
Kyowa Kirin
Co.Ltd-License Agreement...
$676K
License
$96K
(380.00%↑ Y/Y)
Loss before
provision for income taxes
-$16,611K
(12.93%↑ Y/Y)
Provision for income taxes
$110K
(10900.00%↑ Y/Y)
Other income, net
$2,038K
(7.72%↑ Y/Y)
Product
$118,129K
(31.14%↑ Y/Y)
Product And Service
Other
$2,748K
(-63.77%↓ Y/Y)
Gain from operations
-$12,425K
(13.69%↑ Y/Y)
Interest expense
$4,957K
(13.80%↑ Y/Y)
Total revenues
$120,877K
(23.77%↑ Y/Y)
Non-cash interest
expense related to the...
$1,267K
(-42.90%↓ Y/Y)
Total costs and
operating expenses
$133,302K
(33.76%↑ Y/Y)
Selling, general and
administrative
$101,440K
(20.78%↑ Y/Y)
Research and development
$26,103K
(66.62%↑ Y/Y)
Cost of sales
$5,759K
(-53.57%↓ Y/Y)
Buy us a coffee
ARDELYX, INC. (ARDX)
ARDELYX, INC. (ARDX)